An oral vaccine based on the Ad5 vector with a double-stranded RNA adjuvant protects mice against respiratory syncytial virus.
Chai P, Shi Y, Yu J, Liu X, Yang M, Li D, Li K, Li S, Kong X, Zhang Q, Sun X, Li J, Li L, Li D, Duan Z.
Chai P, et al. Among authors: duan z.
Int Immunopharmacol. 2024 Dec 29;146:113970. doi: 10.1016/j.intimp.2024.113970. Online ahead of print.
Int Immunopharmacol. 2024.
PMID: 39736241